These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34114271)

  • 1. Managing Experimental 3D Structures in the Beyond-Rule-of-5 Chemical Space: The Case of Rifampicin.
    Ermondi G; Lavore F; Vallaro M; Tiana G; Vasile F; Caron G
    Chemistry; 2021 Jul; 27(40):10394-10404. PubMed ID: 34114271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational Sampling Deciphers the Chameleonic Properties of a VHL-Based Degrader.
    Ermondi G; Jimenez DG; Rossi Sebastiano M; Kihlberg J; Caron G
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs.
    Danelius E; Poongavanam V; Peintner S; Wieske LHE; Erdélyi M; Kihlberg J
    Chemistry; 2020 Apr; 26(23):5231-5244. PubMed ID: 32027758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs.
    Garcia Jimenez D; Vallaro M; Rossi Sebastiano M; Apprato G; D'Agostini G; Rossetti P; Ermondi G; Caron G
    J Med Chem; 2023 Aug; 66(15):10681-10693. PubMed ID: 37490408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space.
    Ermondi G; Vallaro M; Goetz G; Shalaeva M; Caron G
    Eur J Pharm Sci; 2020 Apr; 146():105274. PubMed ID: 32088315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5.
    Rossi Sebastiano M; Doak BC; Backlund M; Poongavanam V; Over B; Ermondi G; Caron G; Matsson P; Kihlberg J
    J Med Chem; 2018 May; 61(9):4189-4202. PubMed ID: 29608068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to bRo5.
    Rossi Sebastiano M; Garcia Jimenez D; Vallaro M; Caron G; Ermondi G
    J Med Chem; 2022 Sep; 65(18):12068-12083. PubMed ID: 36094896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design Principles for Balancing Lipophilicity and Permeability in beyond Rule of 5 Space.
    Möbitz H
    ChemMedChem; 2024 Mar; 19(5):e202300395. PubMed ID: 37986275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling the Chameleonic Behavior and Membrane Permeability of Cyclosporine Derivatives via Backbone and Side Chain Modifications.
    Lee D; Choi J; Yang MJ; Park CJ; Seo J
    J Med Chem; 2023 Sep; 66(18):13189-13204. PubMed ID: 37718494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell permeability beyond the rule of 5.
    Matsson P; Doak BC; Over B; Kihlberg J
    Adv Drug Deliv Rev; 2016 Jun; 101():42-61. PubMed ID: 27067608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Going Viral: An Investigation into the Chameleonic Behaviour of Antiviral Compounds.
    Wieske LHE; Atilaw Y; Poongavanam V; Erdélyi M; Kihlberg J
    Chemistry; 2023 Feb; 29(8):e202202798. PubMed ID: 36286339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin as an example of beyond-rule-of-5 compound: Ionization beyond water and lipophilicity beyond octanol/water.
    Ermondi G; Vallaro M; Saame J; Toom L; Leito I; Ruiz R; Caron G
    Eur J Pharm Sci; 2021 Jun; 161():105802. PubMed ID: 33716188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space.
    Caron G; Kihlberg J; Goetz G; Ratkova E; Poongavanam V; Ermondi G
    ACS Med Chem Lett; 2021 Jan; 12(1):13-23. PubMed ID: 33488959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and guidelines for discovery of orally absorbed drugs in beyond rule of 5 space.
    Poongavanam V; Doak BC; Kihlberg J
    Curr Opin Chem Biol; 2018 Jun; 44():23-29. PubMed ID: 29803972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?
    Poongavanam V; Danelius E; Peintner S; Alcaraz L; Caron G; Cummings MD; Wlodek S; Erdelyi M; Hawkins PCD; Ermondi G; Kihlberg J
    ACS Omega; 2018 Sep; 3(9):11742-11757. PubMed ID: 30320271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Syntheses Beyond the Rule of 5.
    Tyagi M; Begnini F; Poongavanam V; Doak BC; Kihlberg J
    Chemistry; 2020 Jan; 26(1):49-88. PubMed ID: 31483909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubility prediction in the bRo5 chemical space: where are we right now?
    Ermondi G; Poongavanam V; Vallaro M; Kihlberg J; Caron G
    ADMET DMPK; 2020; 8(3):207-214. PubMed ID: 35300306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.
    Schwochert J; Lao Y; Pye CR; Naylor MR; Desai PV; Gonzalez Valcarcel IC; Barrett JA; Sawada G; Blanco MJ; Lokey RS
    ACS Med Chem Lett; 2016 Aug; 7(8):757-61. PubMed ID: 27563399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry.
    Caron G; Kihlberg J; Ermondi G
    Med Res Rev; 2019 Sep; 39(5):1707-1729. PubMed ID: 30659634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Chameleonic Efficiency.
    David L; Wenlock M; Barton P; Ritzén A
    ChemMedChem; 2021 Sep; 16(17):2669-2685. PubMed ID: 34240561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.